News from Pharmaleads A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jun 29, 2017, 02:00 ET Pharmaleads Reports Positive Phase I SAD Data with its Dual ENKephalinase Inhibitor (DENKI) PL265 for the Treatment of Neuropathic Pain

Pharmaleads, an emerging pharmaceutical company developing innovative products for the management of acute and chronic severe pain, today...


May 12, 2017, 02:00 ET Pharmaleads Reports Positive Ocular Pain Results with PL265, a Novel Dual Enkephalinase Inhibitor (DENKI), at the ARVO 2017 Annual Meeting

Pharmacology research conducted in conjunction with The Vision Institute, Paris Pharmaleads, an emerging pharmaceutical company developing...


May 05, 2017, 03:00 ET Pharmaleads to Present PL265 for Ocular Pain Results at the ARVO 2017 Annual Meeting in Baltimore

Pharmaleads, an emerging pharmaceutical company developing innovative products for the management of acute and chronic severe pain, today...


Feb 09, 2009, 09:00 ET Debiopharm and Pharmaleads Sign License Agreement for Debio 0827 or PL37 in Treatment of Chronic Pain Conditions

Debiopharm Group (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly...